Consolidated Statements of Operations - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
Jan. 31, 2020 |
|
| Income Statement [Abstract] | |||
| Revenue | $ 331,856 | $ 222,990 | $ 228,732 |
| Cost of revenue | 123,724 | 87,417 | 96,023 |
| Gross profit | 208,132 | 135,573 | 132,709 |
| Operating expenses: | |||
| Research and development | 167,337 | 140,759 | 129,724 |
| Selling, general and administrative | 70,438 | 55,980 | 52,634 |
| Total operating expenses | 237,775 | 196,739 | 182,358 |
| Loss from operations | (29,643) | (61,166) | (49,649) |
| Other income, net | 1,002 | 3,863 | 8,021 |
| Loss before income taxes | (28,641) | (57,303) | (41,628) |
| Provision (benefit) for income taxes | (2,230) | 2,483 | 3,164 |
| Net loss | $ (26,411) | $ (59,786) | $ (44,792) |
| Net loss per share attributable to ordinary shareholders: | |||
| Basic | $ (0.72) | $ (1.72) | $ (1.35) |
| Diluted | $ (0.72) | $ (1.72) | $ (1.35) |
| Weighted-average shares used to compute net loss per share attributable to ordinary shareholders: | |||
| Basic | 36,577,120 | 34,679,717 | 33,083,562 |
| Diluted | 36,577,120 | 34,679,717 | 33,083,562 |